Keyphrases
Mesenchymal Stem Cells
100%
Chile
61%
Bipolar Disorder
44%
Exosomes
41%
Preeclampsia
37%
Chilean
34%
Mesenchymal Stromal Cells
27%
Small Extracellular Vesicles
23%
Postsynaptic Density Protein 95 (PSD-95)
22%
T Helper 17 (Th17)
21%
COVID-19
20%
Endometrial Stem Cells
20%
Cell-based
19%
Pregnant Women
18%
T Cells
17%
Extracellular Vesicles
17%
Fluoxetine
17%
MicroRNA
16%
Invasive Pneumococcal Disease
16%
Confidence Interval
15%
Mitochondria
15%
Ischemia-reperfusion Injury
14%
Macrophages
14%
Human Mesenchymal Stem Cells (hMSCs)
14%
Cell Therapy
13%
Astrocytes
13%
Immunization
13%
During Pregnancy
13%
Inducible Nitric Oxide Synthase
13%
Systemic Lupus Erythematosus
12%
First Trimester
12%
Inflammation
12%
Infectious Diseases
12%
Quantitative PCR
12%
Vaccination
11%
Antidepressants
11%
Placenta
11%
Maternal Plasma
11%
Santiago De Chile
11%
Chronic Kidney Disease
11%
Fetus
11%
Rheumatoid Arthritis
11%
Acute Respiratory Distress Syndrome
11%
Selective Intrauterine Growth Restriction (sIUGR)
11%
Gestational Diabetes Mellitus
11%
Noncardiac Surgery
10%
Ischemia Injury
10%
Latin America (LATAM)
10%
Stem Cells
10%
Kidney
9%
Obesity
9%
Meta-analysis
9%
Mitochondrial Transfer
9%
Hypertension
9%
Placebo
9%
Randomized Clinical Trial
9%
Therapeutic Properties
9%
N-methyl-D-aspartate Receptor (NMDAR)
8%
Regulatory T (Treg) Cells
8%
Chronic Dialysis
8%
Experimental Autoimmune Encephalomyelitis
8%
Toll-like
8%
Hypoxia
8%
Hippocampus
8%
Spironolactone
8%
Female Fertility
8%
TrkB
8%
Gestational Age
8%
Neural Stem Cells
8%
Synaptic Plasticity
7%
Cell-derived
7%
Reperfusion
7%
Neisseria Meningitidis
7%
Acute Kidney Injury
7%
Biomaterials
7%
Risk Factors
7%
Pregnancy Trimester
7%
Nitric Oxide
7%
Ischemia
7%
Forebrain
7%
Major Depressive Disorder
7%
Cell-free Fetal DNA
7%
Interleukin-17 (IL-17)
7%
Sepsis
7%
Angiogenesis
7%
Therapeutic Potential
7%
Cell-mediated
7%
Stem Cell Therapy
7%
Myocardial Infarction
7%
NF-B
7%
Central Nervous System
7%
Chronic Stress
7%
PCV10
7%
Regulatory T Cells
7%
Tumor Necrosis Factor-Ī±
7%
Stem Cell-derived
7%
Hemodialysis
7%
Clinical Features
7%
Odds Ratio
6%
Pharmacogenomics
6%
Medicine and Dentistry
Disease
45%
Mesenchymal Stem Cell
42%
Pre-Eclampsia
26%
Stem Cell
25%
Infection
20%
Bipolar Disorder
19%
First Trimester Pregnancy
19%
Serotype
18%
COVID-19
17%
Exosome
14%
Meningococcal Disease
13%
Cell Therapy
13%
Prevalence
12%
Peritoneal Dialysis
11%
Pediatrics
11%
Public Health
11%
Ischemia
11%
Acute Kidney Injury
10%
Gestational Diabetes
10%
Gestational Age
10%
Stromal Cell
10%
Systemic Lupus Erythematosus
10%
Cohort Analysis
10%
Mitochondrion
10%
Placenta
9%
Biological Marker
9%
Messenger RNA
9%
Noncardiac Surgery
8%
In Vitro
8%
Meta-Analysis
8%
Acute Respiratory Distress Syndrome
8%
Intrauterine Growth Retardation
8%
Premature Labor
8%
Female Fertility
8%
Pneumococcus Vaccine
8%
Lung
7%
Maternal Plasma
7%
Pregnancy
7%
microRNA
7%
Randomized Clinical Trial
7%
Apoplexy
7%
Chronic Kidney Disease
7%
Cardiovascular Disease
6%
T Cell
6%
Programmed Cell Death
6%
Trophoblast
6%
Rheumatic Heart Disease
6%
Adipose Tissue
6%
Placebo
6%
Hemodialysis
6%
Neonatal Infant
6%
Reperfusion Injury
6%
Bleeding
6%
Cardiovascular System
6%
Secretion (Process)
6%
Fibroblast Growth Factor 23
6%
Ovarian Cancer
6%
Adolescence
6%
Diagnosis
5%
Severe Acute Respiratory Syndrome Coronavirus 2
5%
Combination Therapy
5%
Rheumatic Fever
5%
Receptor
5%
Anemia
5%
Angiogenesis
5%
Umbilical Cord
5%
Randomized Controlled Trial
5%
Oxidative Stress
5%
Fetus Growth
5%
Case-Control Study
5%
Uterine Artery
5%
Cesarean Section
5%
Neutrophil Gelatinase Associated Lipocalin
5%